EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride): Technical Application Guidance
What This Product Solves
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride, CAS 25952-53-8) is a water-soluble carbodiimide reagent designed for efficient amide bond formation in laboratory protocols. Researchers routinely face challenges achieving high coupling efficiency and minimizing side reactions during peptide synthesis, bioconjugation, and nucleotide synthesis. EDC.HCl activates carboxyl groups to facilitate their reaction with primary amines, enabling direct amide bond formation in aqueous or mixed-solvent systems. Its water solubility and compatibility with diverse substrates make it a preferred choice for in vitro coupling reactions where minimization of organic solvents and avoidance of insoluble byproducts are critical (product_spec).
Importantly, use of EDC.HCl is not recommended for in vivo or clinical protocols due to the absence of supporting data on safety or efficacy in biological systems (internal_guidance).
Protocol Parameters
- assay: Solubility in water | value_with_unit: ≥39 mg/mL | applicability: Solution preparation for peptide synthesis and bioconjugation | rationale: Ensures complete dissolution and homogeneous reaction conditions in aqueous protocols | source_type: product_spec
- assay: Solid storage temperature | value_with_unit: -20°C, desiccated | applicability: Long-term storage of unused reagent | rationale: Maintains chemical integrity and prevents hydrolysis or degradation | source_type: product_spec
- assay: Avoid long-term storage of solutions | value_with_unit: Prepare fresh before use | applicability: All in vitro coupling workflows | rationale: EDC.HCl hydrolyzes in solution and loses activity over time; fresh preparation maximizes coupling efficiency | source_type: product_spec
- assay: Reaction monitoring | value_with_unit: Spectrophotometric quantitation | applicability: QC during peptide or bioconjugate synthesis | rationale: Verifies coupling progress and identifies incomplete reactions | source_type: product_spec
- assay: Typical application concentration | value_with_unit: Workflow-dependent, generally matching substrate molarity | applicability: Peptide, protein, or oligonucleotide coupling | rationale: Stoichiometric or slight excess relative to carboxyl/amine substrates; avoid gross excess to minimize urea byproduct | source_type: workflow_recommendation
Workflow Setup and QC Checklist
For optimal results when using EDC.HCl as a peptide synthesis coupling reagent or bioconjugation reagent, adhere to the following procedural steps:
- Prepare all solutions using freshly deionized water or an appropriate solvent system (e.g., DMSO, ethanol) to reach complete dissolution, not exceeding the maximum stated solubility.
- Confirm the pH of the reaction mixture, typically in the range of pH 4.5–7.5, as EDC-mediated coupling is pH-sensitive; use buffering agents that do not contain primary or secondary amines.
- Combine EDC.HCl with carboxyl-containing substrates, then add the primary amine reactant; the order of addition can affect coupling efficiency.
- Monitor coupling progress using spectrophotometric methods, if available, to confirm reaction completion and detect any precipitation or byproduct accumulation.
- Quench unreacted EDC with appropriate reagents (e.g., excess primary amine or small molecule scavenger) to avoid downstream modification of unintended targets.
- Document all reagent lot numbers, preparation times, and storage conditions as part of standard quality control.
For a detailed technical overview of actionable parameters, refer to EDC.HCl: Technical Guidance, which provides in-depth workflow controls and reproducibility checkpoints for in vitro use.
Common Failure Modes and Fixes
- Incomplete coupling or low yield: Commonly due to EDC.HCl hydrolysis in solution, suboptimal pH, or insufficient reagent. Always prepare solutions fresh, verify pH, and use stoichiometric or slight excess amounts as recommended in the workflow (product_spec).
- Precipitate formation: May result from incompatibility between solvents or buffer components. Use only recommended solvents (water, DMSO, ethanol) and avoid buffers containing primary or secondary amines.
- Byproduct interference (urea formation): Excess EDC.HCl increases urea byproduct, which can complicate purification. Employ minimal effective reagent excess and, if necessary, purify products using desalting or chromatography.
- Loss of reagent activity: Storing EDC.HCl solutions for extended periods leads to degradation. Always store the solid reagent at -20°C, desiccated, and prepare solutions immediately before use (Actionable Protocol Guide offers practical troubleshooting advice for similar workflows).
Scope and Limitations
EDC.HCl is validated for in vitro applications including peptide synthesis, bioconjugation, nucleotide coupling, esterification, and lactonization protocols. It is not appropriate for in vivo or clinical research, as no safety, pharmacokinetic, or efficacy data are available (Protocols & Best Practices). Researchers should not extrapolate its use beyond controlled laboratory workflows without additional validation. The reagent's performance is contingent on strict adherence to storage, preparation, and reaction parameters as deviations may result in compromised yields or side reactions.
Conclusion
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) provides a reliable solution for amide bond formation in peptide synthesis and bioconjugation workflows. Its water solubility and straightforward handling make it a practical choice for in vitro protocols requiring an efficient carbodiimide coupling agent. For further technical details and to source this reagent, refer to EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) from APExBIO. For protocol-specific guidance, cross-reference established internal resources as outlined above. Always restrict use to in vitro applications and rigorously document workflow parameters for reproducibility.